Results 11 to 20 of about 235,116 (346)

Neurotensin receptors in pancreatic ductal carcinomas [PDF]

open access: yesEJNMMI Research, 2015
Abstract Background The frequent expression of neurotensin receptors (NT-R) in primaries of pancreatic ductal carcinomas has triggered the development of radioactive neurotensin analogs for possible in vivo targeting of these tumors.
Körner Jachertz, Meike   +4 more
openaire   +3 more sources

Ca2+ Signaling and Its Potential Targeting in Pancreatic Ductal Carcinoma [PDF]

open access: yesCancers, 2021
Pancreatic cancer (PC) is a major cause of cancer-associated mortality in Western countries (and estimated to be the second cause of cancer deaths by 2030). The main form of PC is pancreatic adenocarcinoma, which is the fourth most common cause of cancer-related death, and this situation has remained virtually unchanged for several decades.
Bettaieb, Louay   +20 more
openaire   +2 more sources

Undifferentiated carcinoma with osteoclast-like giant cells of the pancreas arising from an intraductal papillary mucinous neoplasm

open access: yesHuman Pathology: Case Reports, 2019
Undifferentiated carcinoma of the pancreas with osteoclast-like giant cells is a rare pancreatic tumor of unclear origin. This case reports a 72-year-old male with bloating and indigestion for about six years who was found to have a 5 cm laterally ...
Ahmad Charifa   +3 more
doaj   +1 more source

Adenosquamous carcinoma of the pancreas: A rare and aggressive variant of pancreatic cancer

open access: yesClinical Case Reports, 2022
Adenosquamous carcinoma of the pancreas is a rare and aggressive histological subtype of pancreatic adenocarcinoma, which accounts for 1% to 4% of the exocrine pancreatic malignancies.
Faten Limaiem   +2 more
doaj   +1 more source

Anaplastic (undifferentiated) carcinoma of pancreas, an uncommon variant: Diagnosed on endoscopic-guided fine needle aspiration

open access: yesIndian Journal of Pathology and Microbiology, 2023
Anaplastic carcinoma of pancreas (ACP) are rare pancreatic neoplasms. They are well known to be associated with more aggressive tumor behavior and less favorable prognosis than usual pancreatic ductal adenocarcinoma.
Md Ali Osama, Pooja Bakshi, Kusum Verma
doaj   +1 more source

Expression of matrix metalloproteinase 9 in pancreatic ductal carcinoma is associated with tumor metastasis formation.

open access: yesFolia Histochemica et Cytobiologica, 2007
The objective of the current study was to assess the expression of matrix metalloproteinase 9 (MMP-9) in pancreatic ductal carcinoma and to examine its correlation with chosen clinico-anatomical parameters.
Andrzej Kemona   +4 more
doaj   +1 more source

Common features between neoplastic and preneoplastic lesions of the biliary tract and the pancreas [PDF]

open access: yes, 2019
The bile duct system and pancreas show many similarities due to their anatomical proximity and common embryological origin. Consequently, preneoplastic and neoplastic lesions of the bile duct and pancreas share analogies in terms of molecular ...
Alvaro, D   +10 more
core   +1 more source

Pancreatic ductal adenocarcinoma: Treatment hurdles, tumor microenvironment and immunotherapy

open access: yesWorld Journal of Gastrointestinal Oncology, 2020
Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal diseases, with an average 5-year survival rate of less than 10%. Unfortunately, the majority of patients have unresectable, locally advanced, or metastatic disease at the time of diagnosis.
P. Sarantis   +4 more
semanticscholar   +1 more source

An Autopsy Case of Anaplastic Pancreatic Ductal Carcinoma (Spindle Cell Type) Multiple Onset in the Pancreas

open access: yesCase Reports in Oncology, 2019
This is a case of a 75-year-old man who was diagnosed with anaplastic pancreatic ductal carcinoma (spindle cell type). His image findings showed pancreatic head cysts and pancreatic head, body, and tail tumors respectively.
Hiroyuki Ito   +14 more
doaj   +1 more source

Immunosuppression by monocytic myeloid-derived suppressor cells in patients with pancreatic ductal carcinoma is orchestrated by STAT3

open access: yesJournal of Immunotherapy for Cancer, 2019
BackgroundPancreatic ductal adenocarcinoma (PDAC) is a highly devastating disease with an overall 5-year survival rate of less than 8%. New evidence indicates that PDAC cells release pro-inflammatory metabolites that induce a marked alteration of normal ...
R. Trovato   +23 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy